XtalPi

XtalPi (晶泰科技) is an AI drug discovery company — per 5Y Capital's portfolio page, backed by SoftBank and 5Y Capital . It was also a FreeS Fund portfolio company from the Series A onward . In October 2018, XtalPi closed a $46 million Series B+ round (about RMB 320 million) to expand its intelligent drug R&D platform, bringing its cumulative funding past $66 million — at the time making it one of the highest-funded companies globally in AI-powered drug discovery .